Metabolic syndrome (MetS) has been and remains a highly controversial topic. There is a close association of (MetS) with a group of symptoms associated with diseases of the heart, blood vessels, arteries, and accelerated aging. To find out and discover whether the distribution of these associations or the totals of (MetS) components differ from one gender to another or from one ethnicity to another, 110 subjects were selected as a sample at the National Institute of Diabetes, Nutrition and Metabolic Diseases (N.C.Paulescu) In Bucharest, 110 subjects in divided between 47 Males, 63 females with an age range of 54 years for age groups 35 - 65 years. The pathological conditions in the present study were divided into 2 groups: G1: Patients who have metabolic syndrome. G2: Patients without metabolic syndrome. This study, therefore, aims to diagnose metabolic syndrome according to the criteria approved by ATP III (MetS), also known as insulin resistance syndrome or Syndrome X, which is defined as (a group of several conditions that together increase a person’s risk of developing diabetes and increased heart disease), a disease that is achieved by the presence of 3 or more than 5 components that are considered as parameters or directories (MetS); such as “High level of obesity; High triglyceride levels; High blood sugar level; Decrease in HDL, or good cholesterol and High blood pressure,” but not in a condition in which the person has blood pressure. To achieve this goal, a sample of 110 subjects was selected. An increase in the number of patients with metabolic syndrome at a rate of prevalence (71.1%) of type II Diabetes Patients is among those 110 diabetes patients. Especially among the large age groups, by approximately 55%, Metabolic syndrome was diagnosed in 81 patients, and an apparent increase in the number of female patients with metabolic syndrome (44 females, 37 men). Results have also shown that the metabolic syndrome criterions evolved intrinsically among type 2 diabetes patients with high blood pressure as the highest incidence (79.01%). In contrast, the low level of the high-density lipoprotein had come as the minimal incidence (38.39%). The finding confirmed in this study the data indicates that (MetS) is expected in the category of patients with type 2 diabetes, with an estimated rate of up to 70%. In general, and for people with diabetes in particular, new lifestyles and new health interventions must be followed regarding type 2 diabetes in Romania and the world at large in order to stop or neutralize the burdens, complications, and risk of heart disease in patients with diabetes.
Diabetes is considered a global epidemic with a hazardous and negative impact on human life through a negative impact on body functions in general. It is considered one of the 10 most dangerous diseases that cause death among infected people worldwide. The world deals with two types of diabetes, the most common among patients and the other types (
Whereas type 1 diabetes results from attacking insulin-producing beta cells in the pancreas by the immune system in an autoimmune process. As a result, the body produces little or does not produce it at all. I believe that the explanation for this process is combining genetic susceptibility with environmental factors, which in turn lead to the formation of the “autoimmunity” [
While diabetes mellitus type 2, is the most common type of diabetes, the high level of sugar in the blood is a result of a significant and initial sign as a result of the inability of the body’s cells to perform the maximum response to insulin, causing what is called “insulin resistance” so with the onset of insulin resistance, the hormone is of slight effectiveness. This leads to an increase in insulin production at the right time. Over time, beta cells become unable to meet demand due to insufficient insulin production [
To reduce the risk of this disease, unhealthy practices should be avoided, and irregular control of levels of carbohydrates and fats in food should be avoided, as these factors are among the most critical factors that lead to a steady rise in cases of diabetes among young people. Age groups; Also, high rates of undiagnosed diabetes cases, mainly type 2 diabetes, exceed 50%, a source of concern for society and international health organizations. Those with a cluster of cardiovascular risk factors are more likely to experience cardiovascular problems (such as a heart attack or a stroke) [
Metabolic syndrome is a medical term describing a set of metabolic abnormalities raising the risks of CVD and type II diabetes. Gerald Reaven, an American physician, first described the metabolic syndrome as “X syndrome” in 1988; the World Health Organization named her after her current name in 1999 [
Dietary metabolic syndrome represents a group of dangerous factors related to cardiovascular disease. These include weight gain, central Obesity (abdominal Obesity), insulin resistance and disrupted body fat ratios, and Hypertension [
A group of experts has tried to develop a uniform definition of metabolic syndrome to become more widely accepted than those presented by the WHO, which is the first organization to propose criteria for determining metabolic syndrome in 1999, where this organization in its Diagnosis required proof of either insulin resistance (IR) or Diagnosis of type II diabetes (DM2) through high fasting plasma glucose (FPG) where or reach sugar intake two hours after a glucose tolerance test or Impaired glucose torelance (IGT) or fishery glucose dysfunction Impaired fasting glucose (IFG) and at least 2 of the following 4 criteria [
Regardless of abnormalities in glucose metabolism, people with type 2 diabetes have a significantly increased risk of developing (MetS). The presence of
| Criterion | Clinical value |
|---|---|
| Abdominal obesity | Waist circumference >40 inches for Men/>35 inches for Women |
| Hypertriglyceridemia | ≥150 mg/dL |
| Low HDL cholesterol | <40 mg/dL in Men <50 mg/dL in Women |
| Hypertension | Blood pressure ≥ 130/85 mm/Hg |
| High fasting glucose | ≥110 mg/dL |
(MetS) and type 2 diabetes simultaneously increases the chances of chronic disease of the heart and blood vessels, diseases of the retina, and kidney diseases [
Prevalence studies (MetS) conducted in Romania, especially among Romanian patients with diabetes, are few, so this study evaluated metabolic syndrome in type 2 diabetes and its associated risk factors, and tried to find solutions to reduce the spread of this syndrome, especially among the elderly age group, and urging to follow natural primary treatment methods before going to drug treatment methods, which are not devoid of causing pathological complications and drug interactions that harm the person’s health and cause secondary symptoms in the infected, which are indispensable.
The increasing prevalence of (MetS) makes it a fundamentally global health issue. For this reason, international organizations, conferences, and many researchers have published research and studies that contribute to increasing awareness of the importance of adhering to healthy habits and leaving unhealthy habits to neutralize and reduce factors associated with increased risk of infection of (MetS).
In 2006, the global Prevalence of (MetS) was estimated at 20%. In 2007 the percentage of (MetS) increased to 21.6%, since the overall rate of (MetS) occurrence dropped slightly during the past few years, reaching about 19.5% in 2014, after which it was noted that Prevalence rose again in 2015 when the rate was 22.9%, the increase was particularly prevalent among men, from 22.5% in 2007 to 27.8% in 2018 [
The Prevalence of (MetS) varies from 10.0% to 84.0% worldwide, depending on characteristics such as age and body mass index, according To previous studies and reviews published in 2014. They ranged from 10% among those aged 20-29 (eutrophic) to 45.0% among those aged 60 - 69 (obesity) [
(MetS) has a high incidence in Western European countries than in Eastern European countries. European study looked examined data from 8 cohorts (a total of 8200 men and 9363 women) to determine the Prevalence of (MetS) using WHO’s criteria and then compared those results to those obtained using a different, recommended definition of (MetS) for those who do not have diabetes. Despite the gradual increase in proportion to the increase in age for all persons, the study showed that the prevalence rate of (MetS) among men is about 7% - 36%, while it decreases among women at a rate of 5% - 22% between the ages of 40 - 55 of both Genders [
(MetS) They are risk factors closely related to DM2, cardiovascular disease, strokes, and kidney disease [
The Prevalence of (MetS) in Romania was between 32.74% - 35.66% depending on the criteria used to make the diagnosis, according to a systematic review published in 2016 [
Diabetes mellitus of the second type, the most prevalent worldwide, and (MetS) are linked to a common factor. Obesity, lack of physical activity, and an unbalanced and irregular diet are considered a factor of association between them. Studies indicate that people with (MetS) are 5 times more likely to develop type 2 diabetes than the average person [
The Prevalence of DM2 is increasing at high rates in the world. High blood sugar levels and insulin resistance increase the risk of complications associated with microvascular problems and macrovascular complications. Type 2 diabetes also leads to the production of a group of different pathological disorders, including low glucose balance [
The rising Prevalence of diabetes as a serious health issue is a cause for anxiety. Currently, diabetes affects over half a billion individuals worldwide [
Type 2 diabetes is the most prevalent type among diabetics in the world, with a rate of 90% of all diabetes cases in the world. This type occurs due to problems in the process of regulating sugar in the body and using it to provide the body with energy, as this pathological condition leads to an increase in the level of sugar in the blood. As a result, the levels of sugar in the blood rise and eventually lead to disturbances in the blood circulation, the nervous system and the immune system [
In type 2 diabetes, there are two main problems. The pancreas does not produce enough insulin, the hormone responsible for regulating the movement of sugar in the blood. The second problem is the weak or almost non-existent response to insulin by the cells of the body, and thus the cells obtain very small amounts of sugar [
90% - 95% of non-insulin-dependent diabetes cases are attributable to type 2 diabetes [
Complications related to diabetes, including cardiovascular disease and stroke, are a significant cause of death worldwide. Type 2 diabetes cases are the vast majority of cases of diabetes increases [
Around 8.8% of adults (20 - 79) worldwide have diabetes, or about 415 million individuals, according to data from 220 nations and territories included in the updated IDF Global Atlas of Diabetes. Less than a quarter (25.0%) of those comes from developed countries, with the remainder from developing and less-developed regions. (IDF) the ninth edition of the Diabetes Atlas in 2019 predicts that more than 600 million individuals, or one in ten adults, will have diabetes by 2040 [
Depending at the latest statistics by the International Diabetes Federation (IFDF), there are 537 million cases of diabetes between the age group 20 - 79 years. They are expected to reach 783 million cases in 2045, with an increase in diabetes cases among middle-income countries (
Diabetes affects 18.6% of the world’s population aged 60 - 79, and this age group is projected to see the most significant increase in prevalence. Quantitatively, however, the most incidences are found among those aged 40 to 59. Diabetes is more common among those of modest means. Hence its prevalence is predicted to rise at a faster rate. The prevalence of diabetes increases inversely
| World Bank income classification | 2019 | 2030 | 2045 | |||
|---|---|---|---|---|---|---|
| Prevalence of Diabetes (%) | Number of people with diabetes (Millions) | Prevalence of Diabetes (%) | Number of people with diabetes (Millions) | Prevalence of Diabetes (%) | Number of people with diabetes (Millions) | |
| High-income countries | 10.4 (8.6 - 13.7) | 95.2 (78.7 - 120.9) | 11.4 (9.4 - 14.3) | 107.0 (88.3 - 134.4) | 11.9 (9.8 - 14.8) | 112.4 (92.2 - 139.2) |
| Middle-income countries | 9.5 (7.6 - 12.3) | 353.3 (280.1 - 455.3) | 10.7 (8.4 - 13.7) | 449.6 (353.0 - 576.7) | 11.8 (9.0 - 15.0) | 551.2 (422.7 - 705.2) |
| Low-income countries | 4.0 (2.8 - 6.7) | 14.5 (10.0 - 24.3) | 4.3 (3.0 - 7.1) | 21.9 (15.2 - 36.4) | 4.7 (3.3 - 7.8) | 36.5 (25.8 - 60.2) |
with a country’s GDP; in other words, in countries where people have less money, diabetes is more common [
According to the statistics of the American Diabetes Association, 33% - 49% of people with diabetes lack control over glucose and cholesterol levels in the blood. These factors contribute to an increase in the incidence of diabetes worldwide [
Treatment and prevention of diabetes complications are expected to cost $673 billion worldwide in a conservative analysis, rising to $1197 billion in a more optimistic one. According to international experts in epidemics and diseases, by 2040, treatment and prevention costs will increase to about 1425 billion dollars [
According to the latest studies and research, diabetes mellitus “type 1 and type 2” have a unique or distinctive pathophysiology. The findings of a 2013 study of the pathophysiological and pathogenic mechanisms of diabetes provide evidence that these two forms of diabetes are distinct [
Insulin levels in the blood of people with type 2 diabetes are reliably elevated. By using the oral glucose tolerance test (OTG), we can easily describe the characteristics of (MetS) [
Impaired glucose tolerance and elevated blood plasma insulin levels are conclusive biochemical evidence of (IR). Because insulin levels decrease in type 2 diabetes throughout the transition from intolerance to diabetes, this enhances the character of reduced insulin secretion [
IR (mainly in the liver and muscles) and a decrease in insulin production in pancreatic beta cells play varying roles in the pathogenesis of type 2 diabetes. Both can be affected by upbringing and heredity. The pathogenesis of type 2 diabetes is complex, involving some interrelated factors. One such aspect is the dysregulation of hormone secretion in the entero-hypothalamic and entero-insular axes [
It is now widely known that the steady evolution of insulin resistance (IR) in glucose-intolerant individuals is a crucial factor in the onset of diabetes due to the beta cell’s inability to respond to the rising demand for peripheral insulin. Since the Symptoms and signs of (IR) after onset slightly increases with time, all patients with DM2 have detectable beta cell dysfunction. However, since the progressive decline in beta cell function, the beta cells’ ability to respond to treatment also declines over time [
Noticed rise in baseline insulin concentrations in the blood is seen in the development of (IR), especially in obese people. Some people can keep this gain, while others see it disappear. The former will continue to be neither hyperglycemic nor insulin resistant, whereas the latter will inevitably lose control of their glucose levels [
Compared with the accumulation and evaluation of visceral fat, abdominal fat deposition “central obesity” is associated with a prognosis associated with the syndrome and plays a more significant role in the onset of (IR). This occurs when fatty muscle and liver cells’ normal metabolism is disrupted. Triglyceride metabolites can stimulate hepatic gluconeogenesis and their effects on insulin signaling, glucose transport, phosphorylation, muscle glycogen synthesis, and muscle protein synthesis (
Sometimes IR is insufficient to induce type 2 diabetes effectively; while IR can be considered the primary cause, insulin deficiency can also be regarded as the primary cause.
Moreover, most patients diagnosed with this illness exhibit both conditions. Many people with type 2 diabetes miss it until difficulties have occurred since the disease manifests with less severe symptoms [
Among the metabolic/cardiovascular alterations linked to insulin resistance in the general population, we find systemic arterial Hypertension; Hypercholesterolemia; Obesity (including central obesity), carbohydrate intolerance, Hypercholesterolemia, arterial Hypertension, decreased HDL-c (high-density lipoproteins); Elevated LDL-c (low-density lipoproteins) and hyperuricemia in addition to cardiovascular disease and arteries [
changes. Given these correlations, measuring insulin sensitivity is crucial. There are both direct and indirect measures that can be used for evaluation. The effects of injecting a known insulin dose into a human are studied using natural approaches. On the other hand, endogenous insulin’s influence can be used as a proxy for insulin’s efficacy, especially under homeostatic conditions [
Tests such as “Oral Glucose Tolerance Test, Fasting Blood Insulin, Homeostatic Model Assessment (HOMA), and QUICKI (Quantitative Insulin Sensitivity Screening Box)” are considered methods for measuring insulin resistance [
There are also several other methods for assessing levels of insulin resistance, including measurement of ATIC (means internal carotid artery thickness), clotting factors, enzymes, and hormones [
Many disorders in the organs and tissues, in addition to those disorders associated with diseases of the heart, blood vessels, eyes, nerves, and kidney diseases, these disorders are all linked to diabetes, for example, “retinopathy, amputation of the lower limbs, which results in physical disability” [
Hypoglycemia is one of the severe consequences and complications of diabetes, and it is common for people with diabetes, but sometimes it can also affect people without diabetes, as hypoglycemia is less than 70 mg/deciliter, while when blood sugar levels drop to less than 40 mg/deciliter, this is called an acute hypoglycemic crisis, which in this case leads to deaths, this disorder is more common in patients with type 1 diabetes [
Diabetic retinopathy, a microvascular consequence popular in type 1 and 2 diabetes, is a leading cause of blindness in adults and has been linked to factors like diabetes duration, Hypertension, hyperglycemia, and nephropathy [
Kidney failure is another frequent consequence, and its prevalence in people with diabetes facilitates their clinical progression to dialysis. The most common cause of kidney failure is diabetes, which leads to the condition known as diabetic kidney disease (DKD). The albumin-to-creatinine ratio is a potent cardiovascular risk factor and a DKD marker in type 2 diabetes [
Some complications and disorders, such as “gum disease, Non-Alcoholic fatty liver disease, hearing loss, depression, erectile dysfunction, and fertility problems,” are all related to diabetes [
Every diabetic patient has some metabolic hazards that change in lifestyle or medication must address. NCEP ATP III (National Cholesterol Education Program) and the International Diabetes Federation (IDF) include hyperglycemia, characterized by diabetes glucose levels, as 1 of 5 criteria associated with MetS diagnosis. Most persons with DM2 also meet of criteria for (MetS) [
The practical part of research has been carried out at The National Institute of Diabetes, Nutrition, and Metabolic Diseases “N.C.Paulescu”, where Samples (blood and urine) for people with type II diabetes and randomly, and the use of a carnation Dipstick for microscopic polyproline, kitlegas, lipid profile, and level Blood sugar and pressure system.
The Diagnosis of T2D had been made based on criteria by American Diabetologists Association. All subjects who visited the clinic for 18 months and were diagnosed with T2DM were initially registered. However, for current analysis, only patients for whom all data were available were retained clinical, anthropometric, and biochemical.
Measurements and TestsWe collected blood samples from diabetics during the fasting period and before breakfast, where we pulled 5 ml of blood after sterilization of the drag area; the models drawn from the blood were then placed in sterile, dry, and clean plastic tubes. We left it for half an hour at room temperature, and then we separate the serum from the clotted part with the centrifuge at 3000 cycles/minute and for 10 minutes.
1) Measuring the level of glucose in fasting serum; After fasting 12 hours of fasting according to the principle of enzyme oxidation with Glucose-Oxidase (GOD) enzyme and pink color, there was a fit for this color with the concentration of glucose in the blood serum after measuring absorption at a wavelength of 505 nanometers at a temperature of 21˚C [
2) Measuring triglyceride level TG in fasting serum; After 12 hours of fasting by the Enzymatic Hydrolysis principle after enzyme oxidation, Triglycerides with Lipoprotein Lipase enzyme and the reaction continued until a pink color commensurate with the concentration of triglycerides in the serum after absorption at a wavelength of 505 nanometers at temperature 21˚C [
3) Measuring the level of HDL in blood serum is well-known; LDL, very low-density lipoprotein VLDL, and chylomicrons are found in the blood serum, where laboratory activities in isolation and separation processes are performed carried out by adding chemicals as a solution (Phosphotungstic Acid) which contains magnesium ions; where after the centrifuge procedure, we observe the concentration of cholesterol in HDL and then the separation of these concentrations to precipitate within the laboratory sample, and then the concentration is determined after the measurement of absorption along a specific wavelength of 500 nanometers and at 21˚C [
4) Measuring systolic blood pressure level and diastolic blood pressure; By Rossmax, measurement took place 10 minutes after the patient sat on the backward-based seat and placed the upper limbs to the same level as the heart after which the belt was attached to the hand (above the elbow) and then pressed the operating key as the countdown began to measure the value of systolic and diastolic pressure (mmHg) and its appearance on the device screen.
5) Measuring the level of urinary microscopic protein; Urine samples were taken from people with diabetes in the morning after fasting for 8 - 12 hours (first urine sample). In a 50 ml plastic cup, then dip the screening tape for measuring polycarbonate protein in the insertion to the middle of the indicator mark on the tape for 5 seconds, and then it is taken out and left for a minute, and compare the color in the tape with the colors on the case and read the result with (mg/L).
6) Measurement of Body Mass Index (BMI); Weight (kg) and length (m2) have been measured for each person, after which the BMI has been estimated based on the following formula: weight (kg)/height (m2) [
Results have shown that the number of people who have metabolic syndrome increased for women compared to other patients without syndrome; the total number of patients who have type II diabetes, DM2, (100%) is 110, Males 49 (44.54%) females 61 (55.46%) and an average age of 54 for age groups ranging from between (65 - 35) Year (when whose definition is applied), where the number of patients with metabolic syndrome was 81 (73.63%), 37 males (45.76%), 44 females (54.34%), while the number of those without metabolic syndrome was 29 (26.36%), 11 males (37.93%), female 18 (62.07%) (
The results also showed an increase in the number of people with metabolic syndrome among the large age groups in diabetes/type 2. The number of people who have metabolic syndrome increased from 12 (14.81%) among the age group (35 - 45 years) to 39 (48.14%) among the age group (55 - 65 years) (
Through this study, we have 5 criteria for metabolic syndrome:
1) High-level of fasting glucose sugar;
2) High systolic blood pressure;
3) High BMI;
4) High-level TG triglycerides or low-level HDL lipoprotein;
5) High-level of urinary protein.
| Age groups (1yr) | Number of males (No = 37) | Number of females (No = 44) | Total syndrome (%) (No = 81) |
|---|---|---|---|
| 35 - 45 | 3 (25%) | 9 (75%) | 12 (14.81%) |
| 46 - 55 | 11 (36.66%) | 19 (63.34%) | 30 (37.03%) |
| 56 - 65 | 23 (58.97%) | 16 (41.03%) | 39 (48.14%) |
| Total | 37 (45.67%) | 44 (54.33%) | 81 (100%) |
These results came in various numbers and ratios, with the first order being the standard (Hypertension) of the most significant percentage of metabolic syndrome, where the infection rate was the highest at 79.01% (64 patients) divided into 29 males by 45.31% and 35 females by 54.69%, after the high level of glucose in the blood during Diagnosis because all patients with metabolic syndrome are diabetic/type 2 patients where the infection rate was 100% (81 patients), the total number of people with the syndrome, 37 males at 45.76% and 44 females at 54.34%, (High level of urinary protein) second to infect 62.96% (51 patients) divided into 29 males by 56.86% and 22 by 43.24% followed by the same standard (high level of TG triglycerides) also represents an estimated 62.96% injury to (51 patients) divided into 28 males by 45.90% and 23 females by 54.10%, and in third place was the standard (BMI rise) of 60.49% for (49 patients) divide to 20 males and 29 females by 40.81 percent and ranked fourth standard. High-density lipoprotein HDL level reduced by 38.36% for (23 patients) divided into 10 males by 43.47% and 13 females by 56.53%, which is considered as a single criterion side by side (high level of TG triglycerides) in Diagnosing the metabolic syndrome based on WHO’s definitions of metabolic syndrome. Where lowering the level of HDL has been the lowest ratio among the metabolic syndrome criteria; At the same time, we note that high blood pressure was the highest standard among metabolic syndrome criteria after the high blood glucose standard as the general standard in all patients with DM2; We note as well that the criterion of high BMI was an essential criterion in women compared to males in good male compared to women was the criterion of a high level of urinary protein. The results also showed a low probability of moral differences at probability levels (P > 0.05) in each of the metabolic syndrome diagnosis criteria between males and females (
Results obtained through measurements of blood samples of patients with metabolic syndrome also showed no moral differences in serum glucose levels compared to people without metabolic syndrome.
Results for people with metabolic syndrome showed that there were moral differences in systolic blood pressure levels compared with those without the metabolic syndrome, as there has been an honest increase in systolic blood pressure levels at a level of (P < 0.01). Compared to people without the syndrome as well as results for people with metabolic syndrome showed moral differences in diastolic blood pressure levels compared to people without metabolic syndrome.
Based on our findings as defined by WHO, we note an increase in the number of
| Metabolic syndrome criteria | Males syndrome criteria (%) | Females syndrome criteria (%) | Total syndrome criteria (%) | Moral Differences |
|---|---|---|---|---|
| High-level glucose fasting serum (MML/L) | 37 (45.67) | 44 (54.33) | 81 (100) | (P > 0.05) |
| High blood pressure level (mmHg) | 29 (45.31) | 35 (54.69) | 64 (79.01) | (P > 0.05) |
| High urinary microscopic protein (mg/L) | 29 (56.86) | 22 (43.14) | 51 (62.96) | (P > 0.05) |
| High TG triglycerides in fasting blood serum (MML/L) | 23 (45.10) | 28 (54.90) | 51 (62.96) | (P > 0.05) |
| High body mass index (BMI) (kg/m2) | 20 (40.81) | 29 (59.19) | 49 (60.49) | (P > 0.05) |
| Low high-density lipoprotein HDL in fasting blood serum (Mall/L) | 10 (43.47) | 13 (56.53) | 23 (38.39) | (P > 0.05) |
*(P > 0.05) There are no moral differences between the male and female groups in metabolic syndrome diagnosis criteria.
people with metabolic syndrome amongst DM2 patients, increasing the prevalence of non-communicable disorders like cardiovascular disease [
The results showed a prevalence of metabolic syndrome amongst the women compared to men. These results have been consistent with other studies in several societies in Asia, such as Iran and Pakistan [
The prevalence of metabolic syndrome amongst females compared to males may be due to the rapid development of diabetes complications among women, especially in the large age groups after the interruption of the menstrual period and the disruption of female hormone ratios with a lack of physical activity and eating food with high-calorie levels and its impact on weight gain (high BMI) hence low levels of HDL lipoproteins and estradiol levels [
The results of the diagnostic criteria for metabolic syndrome also showed that high blood pressure had been the maximum ratio of metabolic syndrome after the standard of high fasting glucose sugar as a general criterion for all metabolic syndrome patients, followed by a high level of the UCP and high level of TG triglycerides and then high body mass index and finally the low level of HDL. The cause of Hypertension in diabetes patients is insulin resistance, as it contributes to the expansion of the size of the nearby tube. Therefore, insulin enhances the reabsorption of sodium from the nearby tube [
The high level of urinary microscopic protein among males compared to women is probably due to female sex hormones and their role in protecting against the development of complications of kidney disease, especially in women in the fertility period [
Diabetic nephropathy and high level of protein are directly associated with lipid deficiency, including high levels of TG triglycerides and LDL lipoproteins and low HDL levels among type 2 diabetics due to an imbalance in the metabolism among diabetes patients.
The low level of high-density lipoprotein HDL directly accelerates the process of atherosclerosis amongst people with DM2 by transferring cholesterol from the walls of the arteries to the liver to subtract and dispose of it. So it is called benign or good cholesterol for being rich in protein molecules called apolipoprotein (Apo A-1). Other molecules protect against atherosclerosis and are inversely proportional to TG triglycerides and LDL levels of lipoprotein called bad or malignant cholesterol because it is also rich in protein molecules called apolipoprotein (Apo B), which is a cause of atherosclerosis and when classifying the risk of CVD between the general public and people with diabetes based on acceptable risk scores, edge and high levels of lipid levels in the serum. Most TG and HDL lipoprotein levels for metabolic syndrome patients ranged from risk scores (low risk) to high risk at the edge (medium risk) [
The absence of moral differences in fasting serum glucose levels between the group with the metabolic syndrome and those without it may be because the two groups are type 2 diabetics (Males and Females). Levels of fasting serum glucose for patients with FBS diabetes were the largest or equal to 7 ml/L according to WHO’s Diagnosis of DM2 in patients with the metabolic syndrome [
Persistent deterioration in the function of insulin-producing cells is frequently observed in DM2 patients due to a potential role of oxidative stress, which diabetes patients experience daily due to chronic elevations in blood glucose, resulting in disease development and its increased complications [
There are moral differences in the systolic blood pressure levels and diastolic blood pressure compared to people without the syndrome, perhaps because most of the individuals with the metabolic syndrome, most of whom had no hypertension, among people with DM2.
Diabetes patients have a higher likelihood of developing high blood pressure than non-diabetes. This interconnectedness increases as the patient ages and the more prolonged diabetes is developed, and hypertension cases increase in developing countries.
High blood pressure levels are strongly related to insulin resistance, even in the case of non-diabetes. At the same time, 40% - 70% of people with DM2 develop high blood pressure due to insulin resistance [
Our study’s factor analysis results argue that the relationships between the variables that classically compose MetS are best explained through the prism of multiple physiological processes. At the same time, identified factors do not fully explain the pathogenesis of MetS, requiring further studies and, perhaps, introducing new components or markers to explain the phenomenon comprehensively. Our results play a role in better understanding the pathophysiology of MetS in T2DM patients, which could translate into practice through the development of prevention and treatment strategies that target mechanisms responsible for the simultaneous occurrence of several MetS components.
Increase the MetS prevalence amongst people with DM2, especially the large age groups, especially women. Most metabolic syndrome patients have high blood pressure, high urinary protein, high triglyceride levels, and high BMI (obesity). Furthermore, low levels of high-density lipoprotein after having DM2 thus contribute to each of the syndrome criteria to increased heart and vascular disease risks related to high mortality among metabolic syndrome patients.
Improving lifestyle and lifestyle remains the most appropriate and best solution. The initial treatment measures for those with MetS are following specific diet and exercise recommendations and controlling behavioral practices, emphasizing medication use for people with MetS who have not had apparent progression. Improve when these measures are followed.
For example, the person’s immediate surroundings (housing or geographical location) may encourage this disorder. Factors like labor and working conditions, sanitation, and social norms, to name a few, might be considered alongside environmental factors.
Socioeconomic status is associated with an increase or decrease in the prevalence of (MetS), diabetes mellitus, and cardiovascular disease, as well as the pathological complications associated with these diseases.
There was a wide range of approaches to assessing (MetS) in many systematic reviews. One of them created a hierarchical classification of these techniques according to their usefulness, with the NCEP ATP III (2001) at the top, followed by the modified 2005 (AHA/NHLBI) version, then the WHO (1998) version, and finally the modified WHO (1998) version (1999). According to the findings, the high degree of variability between type 2 diabetes and (MetS) may be attributable to the similarity in diagnostic criteria between the two diseases.
Obesity, Hypertension, uncontrolled hyperglycemia, high triglyceride and LDL-c levels, and low HDL-c levels are more common in women than men when comparing (MetS) components in a sample of people with type 2 diabetes. According to the same scientists, these changes tend to worsen with age in this population and could contribute to cardiovascular risk.
It has been noted worldwide that a comprehensive and integrated approach is necessary to effectively address not only diabetes but also the spectrum of comorbidities such as (MetS) that may coexist with it.
To review and evaluate the surrounding health conditions, epidemics, and diseases, it is advised that more studies be developed on this topic, comparable to those made in eastern and developing countries. It would be fascinating to analyze how the cultural norms of each continent’s people might affect the spread of the disease, (MetS) has not been recorded in young age groups and children, and this path allows us to carry out prevention and focus therapeutic steps in the stages of childhood and adolescence to avoid the occurrence of this syndrome and its associated risk factors.
The authors declare no conflicts of interest regarding the publication of this paper.
Albajy, M.A., Mihailescu, D., Alexandra, M. and Maranda, I. (2023) Prevalence of Metabolic Syndrome in People with Type 2 Diabetes in Romania. Journal of Biosciences and Me- dicines, 11, 247-268. https://doi.org/10.4236/jbm.2023.115018